Dromer, Françoise <br/><br/>
Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.  [electronic resource] 

 -  PLoS medicine  Feb 2007 
 - e21 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-1676 
<br/><br/><label>Standard No.: </label>10.1371/journal.pmed.0040021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS-Related Opportunistic Infections--drug therapy<br/>Adult<br/>Amphotericin B--therapeutic use<br/>Antifungal Agents--therapeutic use<br/>Cryptococcosis--cerebrospinal fluid<br/>Cryptococcus neoformans--classification<br/>Female<br/>Flucytosine--therapeutic use<br/>France--epidemiology<br/>Humans<br/>Male<br/>Meningoencephalitis--drug therapy<br/>Prospective Studies<br/>Severity of Illness Index<br/>Treatment Outcome